Less Ads, More Data, More Tools Register for FREE

IN BRIEF: International Biotechnology Trust NAV rises over interim

Mon, 26th Apr 2021 14:35

International Biotechnology Trust PLC - investment trust run by SV Health Managers LLP - reports net asset value as of February 28 increased to 776 pence per share from 739p per share as at August 31. Net asset value on total return was 6.9% in period, underperforming benchmark Nasdaq Biotechnology Index return of 12%. Pretax profit more than doubled year-on-year to GBP19.1 million from GBP9.3 million.

Underperformance versus benchmark attributed to unsustainably high valuations of early-stage companies with no clinical data, which International Biotechnology Trust did not invest in. Investment strategy and dividend policy remain unchanged. Company will continue to issue shares at premium to net asset value to satisfy market demand.

Current stock price: 748.00 pence

Year-to-date change: down 8.5%

By Ivan Edwards; ivanedwards@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Related Shares

More News

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

20 Aug 21 16:10

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

8 Jul 21 15:59

IN BRIEF: International Biotechnology Trust NAV rises over interim

IN BRIEF: International Biotechnology Trust NAV rises over interim

26 Apr 21 14:35

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

19 Apr 21 16:05

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.